0.8332
Tenaya Therapeutics Inc (TNYA) 最新ニュース
What is Tenaya Therapeutics Inc. company’s growth strategyDiscover market opportunities with real-time data - jammulinksnews.com
Why Tenaya Therapeutics Inc. stock attracts strong analyst attentionAI Powered Stock Call - Newser
What are the latest earnings results for Tenaya Therapeutics Inc.Free Trend-Following Techniques - jammulinksnews.com
What is the dividend policy of Tenaya Therapeutics Inc. stockSuperior profit margins - jammulinksnews.com
What institutions are buying Tenaya Therapeutics Inc. stock nowFree Stock Market Beginners Guide - Newser
Is Tenaya Therapeutics Inc. a Top Dividend Stock to Watch in 2025Consistent Win Signals - Newser
Intrinsic Value of Tenaya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedCapital Growth Picks - Newser
Is Tenaya Therapeutics Inc. stock a growth or value playFree Investment Risk Control - jammulinksnews.com
What analysts say about Tenaya Therapeutics Inc. stockAccelerated investment success - PrintWeekIndia
What drives Tenaya Therapeutics Inc. stock pricePowerful profit generation - Autocar Professional
Tenaya Therapeutics Inc. Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com
Is Tenaya Therapeutics Inc. a good long term investmentRapid profit acceleration - jammulinksnews.com
How Tenaya Therapeutics Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
What makes Tenaya Therapeutics Inc. stock price move sharplyFree Best Performing Stock Suggestions - Newser
58,547 Shares in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Bought by Wealth Enhancement Advisory Services LLC - Defense World
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 0.3% – Here’s Why - Defense World
FDA clears Rocket Pharmaceuticals’ IND for gene therapy candidate - BioWorld MedTech
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) market cap surged US$12m last week, private equity firms who have a lot riding on the company were rewarded - simplywall.st
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World
Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com India
Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia
大文字化:
|
ボリューム (24 時間):